Expression levels of gp130 in bone marrow stromal cells determine the magnitude of osteoclastogenic signals generated by IL-6-type cytokines

Journal of Cellular Biochemistry

Volumn 79, Issue 4, 2000, Pages 532-541

  O'Brien, Charles A ^a,b   Lin, Song Chang ^a   Bellido, Teresita ^a   Manolagas, Stavros C ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Oncostatin M; Osteoblast; RANKL; Receptor; STAT3

Indexed keywords

DOXYCYCLINE; GLYCOPROTEIN GP 130; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; STAT3 PROTEIN;

ANIMAL CELL; ARTICLE; BONE MARROW; CONTROLLED STUDY; MOUSE; NONHUMAN; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

3T3 CELLS; ANIMAL; ANTIGENS, CD; BONE MARROW CELLS; CELL LINE; CELLS, CULTURED; DNA-BINDING PROTEINS; GENE EXPRESSION; INTERLEUKIN-5; MEMBRANE GLYCOPROTEINS; MICE; OSTEOCLASTS; PEPTIDES; RECEPTORS, INTERLEUKIN-6; SIGNAL TRANSDUCTION; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; TRANS-ACTIVATORS;

ANIMALIA;

EID: 0033785491     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-4644(20001215)79:4<532::AID-JCB20>3.0.CO;2-U     Document Type: Article

References (51)

1. Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor
2. Activation of the Janus kinase/STAT (signal transducer and activator of transcription) signal transduction pathway by interleukin-6-type cytokines promotes osteoblast differentiation
3. Transcriptional activation of the p21(WAF1,CIP1,SDI1) gene by interleukin-6 type cytokines - A prerequisite for their pro-differentiating and anti-apoptotic effects on human osteoblastic cells
4. Chinese hamster ovarian cells transfected with the murine interleukin-6 gene cause hypercalcemia as well as cachexia, leukocytosis and thrombocytosis in tumor-bearing nude mice
5. Dual T cell receptor T cells have a decreased sensitivity to physiological ligands due to reduced density of each T cell receptor
6. Ciliary neurotrophic factor/leukemia inhibitory factor/interleukin 6/oncostatin M family of cytokines induces tyrosine phosphorylation of a common set of proteins overlapping those induced by other cytokines and growth factors
7. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins
8. 17-Beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: A potential mechanism for the antiosteoporotic effect of estrogens
9. Interleukin-11: A new cytokine critical for osteoclast development
10. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters
11. Transcriptional activation by tetracyclines in mammalian cells
12. A role for interleukin-6 in parathyroid hormone-induced bone resorption in vivo
13. Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress
14. Increased osteoclast development after estrogen loss: Mediation by interleukin-6
15. Linkage of decreased bone mass with impaired osteoblastogenesis in a murine model of accelerated senescence
16. Osteoblast programmed cell death (apoptosis): Modulation by growth factors and cytokines
17. Osteoclasts are present in gp130-deficient mice
18. Cytokine signal transduction
19. Interleukin-6 family of cytokines and gp130
20. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymphnode organogenesis
21. IL-6 stimulates osteoclast-like multinucleated cell formation in long term human marrow cultures by inducing IL-1 release
22. Influence of subunit combinations on signaling by receptors for oncostatin M, leukemia inhibitory factor, and interleukin-6
23. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
24. Regulation of the gp80 and gp130 subunits of the IL-6 receptor by sex steroids in the murine bone marrow
25. Cloning and characterization of a specific receptor for mouse oncostatin M
26. Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130
27. Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation
28. IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase
29. A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells
30. Isolation and characteization of the human gp130 promoter. Regulation by STATS
31. STAT3 activation in stromal osteoblastic cells is required for induction of the receptor activator of NF-kappa B ligand and stimulation of osteoclastogenesis by gp130-utilizing cytokines or interleukin-1 but not 1,25-dihydroxyvitamin D-3 or parathyroid hormone
32. Inhibitory effect of all-trans retinoic acid on the growth of freshly isolated myeloma cells via interference with interleukin-6 signal transduction
33. Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy
34. Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex
35. Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion
36. The role of gp130-mediated signals in osteoclast development: Regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures
37. Parathyroid hormone (PTH) excess is associated with increased interleukin-6 (IL-6) and soluble IL-6 receptor (sIL-6r) production
38. Up-regulation of the interleukin-6-signal transducing protein (gp130) by interleukin-6 and dexamethasone in HepG2 cells
39. Enhancement of IL-6 receptor beta chain (gp130) expression by IL-6, IL-1 and TNF in human epithelial cells
40. The alphas, betas, and kinases of cytokine receptor complexes
41. Cells of bone: Osteoclast generation
42. Continuous perfusion with interleukin 6 (IL-6) enhances production of hematopoietic stem cells (CFU-S)
43. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6
44. Differential regulation of macrophage differentiation in response to leukemia inhibitory factor/oncostatin-M/interleukin-6: The effect of enforced expression of the SCL transcription factor
45. Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension
46. Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors
47. The effects of androgen deficiency on murine bone remodeling and bone mineral density are mediated via cells of the osteoblastic lineage
48. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone
49. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
50. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene
51. The effects of twelve weeks of bed rest on bone histology, biochemical markers of bone turnover, and calcium homeostasis in eleven normal subjects